Academic research institutions play a crucial role in the drug development process, especially on the preclinical research and drug discovery side, as Big Pharma companies are increasingly cutting back their R&D spending. We've taken a look at some of the best research institutions in the U.S. and ranked by them by their level of funding from the National Institutes of Health, the largest funder of biomedical research in the world.
Illumina is a company that has become used to success. Yet this week a collaboration between Illumina and The Scripps Research Institute lost to a Stanford University-led academic consortium in a bid for a $40 million grant to set up a stem cell genomics center in California.
Memorial Sloan-Kettering Cancer Center in New York now has an extra $90 million to devote to cancer immunotherapy research.
Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...
The Nobel Assembly at Karolinska Institutet of Sweden has awarded the Nobel Prize in physiology or medicine to three scientists at U.S. universities for unraveling the intricacies behind how molecules are transported in the cell and delivered to the right place at the right time.
A stealth biotech spun out of Stanford University burst into public view today, drawing headlines around the world for its new therapeutic approach to Type 1 diabetes that aims to completely change the standard of care in the field.
A team of researchers at the Stanford University School of Medicine has developed a data mining method that could divulge important information about possible drug side effects using records of interactions between doctors and patients.
Tech visionary Peter Thiel, recently named one of FierceBiotech 's top biotech billionaires and an early venture investor in Facebook, has chosen two recipients of the first round of grants of up to $350,000--Stealth Biosciences and Skyphrase, which are both developing innovative technologies that could have uses in the biopharma space.
A Stanford University research team has concocted a new process that allowed them to make a mouse's brain completely transparent to the point of seeing detailed neuronal networks inside.
Personalis emerged from the crowd of new genomic analysis outfits with news of a contract from the U.S. Department of Veterans Affairs (VA).